Clifford Chance has been recognised at the LMG Life Sciences EMEA Awards 2026 in six categories:

Firm of the Year

• Patent Litigation Firm of the Year: Pharmaceuticals
• Germany Firm of the Year

Deal Awards:

• M&A Impact Deal: Merck KGaA / SpringWorks
• Capital Markets & Financing Impact Deal: NanoPhoria Series A financing

Lawyer of the Year Awards

• Patent Litigator of the Year: Pharmaceuticals: Tobias J Hessel
• Banking and Capital Markets Rising Star: Luke Ng

Torsten Syrbe, Partner, Co-Chair of the Healthcare & Life Sciences sector group, said: “The recognitions we have received at the LMG Life Sciences EMEA Awards 2026 reflect our colleagues’ commitment, insight and expertise in supporting clients across the sector. We look forward to building on this success and continuing to deliver innovative solutions for our clients in the years ahead.”

The LMG Life Sciences EMEA Awards recognise the most outstanding law firms and lawyers specialised in the life sciences industry across Europe, the Middle East and Africa. The annual awards ceremony for the 2026 awards took place on 4 June 2026 in London.